159 related articles for article (PubMed ID: 37958439)
21. [Different treatment regimens for primary central nervous system lymphoma:based on SEER database].
Yang CW; Ren XH; Jiang HH; Li MX; Zhao XZ; Zhu QH; Cui Y; Lin S
Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):52-58. PubMed ID: 33412634
[No Abstract] [Full Text] [Related]
22. The Cleveland Clinic experience with primary central nervous system lymphoma.
Xie H; Ahluwalia MS; Peereboom DM
Am J Clin Oncol; 2015 Apr; 38(2):140-6. PubMed ID: 23608829
[TBL] [Abstract][Full Text] [Related]
23. A single-center retrospective analysis of outcome measures and consolidation strategies for relapsed and refractory primary CNS lymphoma.
Bonm AV; Gibson AW; Holmberg LA; Mielcarek M; McGranahan T; Taylor LP; Graber JJ
J Neurooncol; 2021 Jan; 151(2):193-200. PubMed ID: 33398532
[TBL] [Abstract][Full Text] [Related]
24. Survival, prognostic factors, hospitalization time and clinical performance status after first cerebral relapse or progression in 54 patients with primary CNS lymphoma not eligible for high dose chemotherapy: a retrospective analysis.
Seidel S; Kowalski T; Nilius-Eliliwi V; Schroers R; Schlegel U
Neurol Res Pract; 2023 Feb; 5(1):8. PubMed ID: 36814351
[TBL] [Abstract][Full Text] [Related]
25. Surgical Resection for Primary Central Nervous System Lymphoma: A Systematic Review.
Labak CM; Holdhoff M; Bettegowda C; Gallia GL; Lim M; Weingart JD; Mukherjee D
World Neurosurg; 2019 Jun; 126():e1436-e1448. PubMed ID: 30904794
[TBL] [Abstract][Full Text] [Related]
26. Stereotactic Radiosurgery in the Treatment of Recurrent CNS Lymphoma.
Kumar R; Laack N; Pollock BE; Link M; O'Neill BP; Parney IF
World Neurosurg; 2015 Aug; 84(2):390-7. PubMed ID: 25868718
[TBL] [Abstract][Full Text] [Related]
27. Surgery for primary CNS lymphoma? Challenging a paradigm.
Weller M; Martus P; Roth P; Thiel E; Korfel A;
Neuro Oncol; 2012 Dec; 14(12):1481-4. PubMed ID: 22984018
[TBL] [Abstract][Full Text] [Related]
28. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
[TBL] [Abstract][Full Text] [Related]
29. Accuracy and safety of 101 consecutives neurosurgical procedures for newly diagnosed central nervous system lymphomas: a single-institution experience.
Aliouat I; Moiraghi A; Simboli GA; Birsen R; Elia A; Roux A; Tamburini J; Dezamis E; Parraga E; Benevello C; Damotte D; Provost C; Oppenheim C; Bouscary D; Chretien F; Zanello M; Pallud J
J Neurooncol; 2022 Sep; 159(2):347-358. PubMed ID: 35759152
[TBL] [Abstract][Full Text] [Related]
30. Assessing the Safety of Craniotomy for Resection of Primary Central Nervous System Lymphoma: A Nationwide Inpatient Sample Analysis.
Yun J; Yang J; Cloney M; Mehta A; Singh S; Iwamoto FM; Neugut AI; Sonabend AM
Front Neurol; 2017; 8():478. PubMed ID: 28955300
[TBL] [Abstract][Full Text] [Related]
31. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
32. Toxicity and efficacy of CAR T-cell therapy in primary and secondary CNS lymphoma: a meta-analysis of 128 patients.
Cook MR; Dorris CS; Makambi KH; Luo Y; Munshi PN; Donato M; Rowley S; Saad A; Goy A; Dunleavy K; Ali A
Blood Adv; 2023 Jan; 7(1):32-39. PubMed ID: 36260735
[TBL] [Abstract][Full Text] [Related]
33. Autologous Stem Cell Transplantation in Central Nervous System Lymphoma: A Multicenter Retrospective Series and a Review of the Literature.
Dholaria BR; Kumar A; Azzuqua AG; Nishihori T; Kharfan-Dabaja MA; Tun HW; Ayala E
Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):e273-e280. PubMed ID: 30914301
[TBL] [Abstract][Full Text] [Related]
34. Role of rituximab in treatment of patients with primary central nervous system lymphoma: a retrospective analysis of the Czech lymphoma study group registry.
Mocikova H; Pytlik R; Sykorova A; Janikova A; Prochazka V; Vokurka S; Berkova A; Belada D; Campr V; Buresova L; Trneny M;
Leuk Lymphoma; 2016 Dec; 57(12):2777-2783. PubMed ID: 27087066
[TBL] [Abstract][Full Text] [Related]
35. The outcome of ibrutinib-based regimens in relapsed/refractory central nervous system lymphoma and the potential impact of genomic variants.
Wang S; Zhu Y; Qian X; Ding T; Yuan Y; Li Y; Wu H; Chen T
Adv Clin Exp Med; 2023 Aug; 32(8):855-863. PubMed ID: 36881367
[TBL] [Abstract][Full Text] [Related]
36. The value of bone marrow biopsy for staging of patients with primary CNS lymphoma.
Margold M; Seidel S; Kowalski T; Ladigan-Badura S; Baraniskin A; Schroers R; Frey AV; Schmidt-Wolf IGH; Herrlinger U; Korfel A; Schlegel U
Neuro Oncol; 2021 Dec; 23(12):2076-2084. PubMed ID: 33984138
[TBL] [Abstract][Full Text] [Related]
37. Parenchymal central nervous system involvement in aggressive B-cell lymphoma: retrospective analysis of clinical and MRI features in a Chinese population.
Wu Y; Wang Y; Sun X; Bai X; Qian J; Zhu H; Cui Q; Xing R; Chen Y; Liu Q; Guo J; Ji N; Sun S; Liu Y
BMC Neurol; 2019 Nov; 19(1):268. PubMed ID: 31684888
[TBL] [Abstract][Full Text] [Related]
38. Primary central nervous system lymphoma: variety of clinical manifestations and survival.
Kim DG; Nam DH; Jung HW; Choi KS; Han DH
Acta Neurochir (Wien); 1996; 138(3):280-9. PubMed ID: 8861696
[TBL] [Abstract][Full Text] [Related]
39. Stereotactic radiosurgery in combination with up-front high-dose methotrexate as a first-line treatment for newly diagnosed primary central nervous system lymphoma.
Hirono S; Iwadate Y; Higuchi Y; Serizawa T; Nagano O; Matsutani T; Saeki N
J Neurooncol; 2015 Jun; 123(2):237-44. PubMed ID: 25911295
[TBL] [Abstract][Full Text] [Related]
40. Intraocular involvement is associated with a high risk of disease relapse in primary central nervous system lymphoma.
Zhuang L; Lai J; Chen K; Ding T; Yuan Y; Ma Y; Kang H; Lin Z; Fan N; Ma J; Zeng Q; Xu X; Wang Q; Chen B
Oncol Rep; 2019 Jan; 41(1):397-404. PubMed ID: 30320386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]